Be in the know. 15 key reads for Friday…

  1. China passes major data protection law as regulatory scrutiny on tech sector intensifies (CNBC)
  2. AstraZeneca Seeks Approval of Landmark Antibody Drug Preventing Covid Symptoms (Barron’s)
  3. The Delta variant has derailed the speed of the economic recovery and will prompt the Fed to delay tapering plans, Guggenheim’s Minerd says (Business Insider)
  4. 4 Healthcare Stocks That Analysts Love (Barron’s)
  5. BlackRock calls for investors to lift allocations to China’s markets (Financial Times)
  6. Chinese regulators meet with developer Evergrande as scrutiny on real estate grows (CNBC)
  7. Here’s why the ultra-wealthy like Bill Gates and Thomas Petterfy are investing in U.S. farmland (CNBC)
  8. Ark’s Cathie Wood Says the Stock Market ‘Couldn’t Be Further Away From a Bubble.’ Here’s Why. (Barron’s)
  9. Intel CEO Calls Chip Maker ‘Willing Buyer’ as Semiconductor Industry Consolidates (Wall Street Journal)
  10. CVS, Walgreens Look for Sales Bump From Covid-19 Boosters (Wall Street Journal)
  11. China Passes One of the World’s Strictest Data-Privacy Laws (Wall Street Journal)
  12. The Dream Cars of the Car Designers (New York Times)
  13. Exclusive-China eyes pushing U.S. IPO-bound firms to hand over data control-sources (Yahoo! Finance)
  14. Billionaire John Paulson Goes Big on These 2 High-Yield Dividend Stocks (Yahoo! Finance)
  15. Biggest Tax Hike on Wealthy Since ‘93 Is Bogged Down in U.S. Congress (Bloomberg)

Unusual Options Activity – Alibaba Group Holding Limited (BABA)

Data Source: barchart

Today some institution/fund purchased 4,910 contracts of Jan 2023 $170 strike calls (or the right to buy 491,000 shares of Alibaba Group Holding Limited (BABA) at $170). The open interest was just 856 prior to this purchase. Continue reading “Unusual Options Activity – Alibaba Group Holding Limited (BABA)”